Skip to main content
SMFM 2025 Pregnancy Meeting Main banner
Final Program


Program Book
Icon Legend
Presentation Icons
Additional registration fee required
Additional registration fee required
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Poster Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared on social media
Faculty have requested this content not be shared on social media
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Back

Tracy A. Manuck, MD, MSCI (she/her/hers)

Professor
University of North Carolina
Chapel Hill, North Carolina, United States

Tracy Manuck, MD, MS, is a Professor in the Department of Obstetrics and Gynecology at the University of North Carolina at Chapel Hill in the Division of Maternal-Fetal Medicine where she serves as Medical Director of the Prematurity Prevention Program. Dr. Manuck is the Perinatal Section Head for the Institute for Environmental Health Solutions. She is a two-time award winner of the National March of Dimes award for the Best Research in Prematurity. Dr. Manuck is nationally and internationally renowned for her clinical and translational research and has served on multiple Society for Maternal Fetal Medicine committees and special task forces and given invited lectures worldwide.

Dr. Manuck is actively involved in teaching and mentoring and serves as co-Director of Maternal-Fetal Medicine fellow research at UNC and Director of OBGYN Resident Research. Her clinical interests and expertise include adverse pregnancy outcomes - specifically, preterm labor, cervical insufficiency, and placentally-mediated adverse outcomes, with a focus on how racial and ethic disparities and environmental exposures contribute to these and other clinical outcomes. Dr. Manuck's work focuses on applying solution-oriented translational research approaches to improve care for individuals at highest risk for these adverse outcomes. Dr. Manuck is an expert in personalized medicine within obstetrics and actively engaged in NIH-funded translational research aimed at identifying individuals at highest risk for PTB and/or most likely to respond to interventions to prevent adverse outcomes.

Presentation(s):